ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,523Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 247

$627K Total Retail Price of All Prescriptions

Rank: 21 out of 247

519 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 519 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

15% of this provider’s 519 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 5,550 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LISINOPRIL 427 303 1 2
LEVOTHYROXINE SODIUM 385 269 2 3
SIMVASTATIN 365 262 3 1
OMEPRAZOLE 310 135 4 4
METFORMIN HCL 251 175 5 12
METOPROLOL TARTRATE 249 191 6 7
AMLODIPINE BESYLATE 247 202 7 6
FUROSEMIDE 238 152 8 5
ATORVASTATIN CALCIUM 231 160 9 8
HYDROCODONE-ACETAMINOPHEN 224 81 S3 10 11
HYDROCHLOROTHIAZIDE 213 170 11 9
METOPROLOL SUCCINATE 212 116 12 14
OXYCODONE HCL 202 53 S2 13 27
QUINAPRIL HCL 195 93 14 105
ATENOLOL 129 88 15 10
GABAPENTIN 119 48 16 17
NEXIUM 116 41 17 42
PRAVASTATIN SODIUM 114 81 18 23
SERTRALINE HCL 112 36 19 16
CRESTOR 102 45 20 30
FLUTICASONE PROPIONATE 102 66 20 37
ADVAIR DISKUS 97 49 22 18
ISOSORBIDE MONONITRATE ER 92 76 23 40
CYCLOBENZAPRINE HCL 91 20 R 24 54
RANITIDINE HCL 90 34 25 34
CITALOPRAM HBR 86 51 26 20
PROAIR HFA 79 42 27 29
ALLOPURINOL 79 55 27 33
ZOLPIDEM TARTRATE 78 37 29 24
COMBIVENT 78 0 29 63
JANTOVEN 77 48 31 76
DIOVAN 71 70 32 38
FINASTERIDE 66 49 33 73
TRAZODONE HCL 61 20 34 28
AZITHROMYCIN 60 35 35 48
NITROSTAT 58 48 36 111
WARFARIN SODIUM 58 54 36 13
BUPROPION XL 55 15 38 91
SPIRIVA 54 27 39 26
LOSARTAN POTASSIUM 52 46 40 15
GEMFIBROZIL 50 23 41 126
DOXAZOSIN MESYLATE 50 24 41 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.